Bill Snyder Archive — Page 55 of 121

Kathryn Edwards, MD, was honored for her contributions to pediatrics and vaccine research.
November 14, 2019

Edwards receives American Pediatric Society’s top award

Vanderbilt’s Kathryn Edwards, MD, is the recipient of the 2020 John Howland Award, the highest honor given by the American Pediatric Society (APS).

Brain image
November 14, 2019

Blueprint for treating epilepsy

Structural details of a protein that is essential to normal brain function could improve treatments for epilepsy and other seizure disorders.

November 5, 2019

Endotoxin shock protector

A novel tool developed by Vanderbilt scientists protects animals from endotoxin shock and can be used for mechanistic analyses of inflammation due to microbial and other insults.

False-color molecular image of a rounded biological tissue section, with green outer regions, a yellow band, and a pink-purple inner ring surrounding a darker green center. Labels at the bottom identify three molecular signals: m/z 888.5564 3C13 PI(36:4), m/z 888.5711 13C PI(36:3), and m/z 888.6248 SulfoHex-Cer(d18:2/24:0).
October 31, 2019

Vanderbilt investigators lead effort to create map of the human kidney

Short of mandating universal diabetes treatment, regular exercise and low-calorie diets, little can be done to stem the rising tide of kidney failure — unless scientists can figure out why exactly the kidney’s filtration units, the glomeruli, stop working.

Man in a dark suit and pink tie standing with his hands clasped in front of a modern glass building and greenery.
October 24, 2019

Wang to chair Department of Internal Medicine at UT Southwestern Medical Center

Thomas Wang, MD, director of Cardiovascular Medicine at VUMC, has been appointed chair of Internal Medicine at the University of Texas Southwestern Medical Center in Dallas, effective February 2020.

Portrait of Dan Roden, MD, wearing a suit and patterned tie.
October 24, 2019

Article examines need for genotyping after stenting

Genotyping can improve outcomes in patients who require anti-platelet therapy following stent placement to open narrowed or blocked coronary arteries and prevent a heart attack.